Bridgeway Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-83,800
| Closed | -$482K | – | 1300 |
|
|
2021
Q2 | $482K | Buy |
83,800
+20,800
| +33% | +$120K | 0.01% | 1075 |
|
|
2021
Q1 | $290K | Sell |
63,000
-26,500
| -30% | -$122K | 0.01% | 1231 |
|
|
2020
Q4 | $299K | Sell |
89,500
-14,900
| -14% | -$49.8K | 0.01% | 1120 |
|
|
2020
Q3 | $310K | Buy |
104,400
+63,000
| +152% | +$187K | 0.01% | 1052 |
|
|
2020
Q2 | $191K | Hold |
41,400
| – | – | ﹤0.01% | 1159 |
|
|
2020
Q1 | $159K | Buy |
+41,400
| New | +$159K | ﹤0.01% | 1115 |
|